MedMira Gains Mexican Approval For Reveal HIV Test


MedMira has received approval from the Federal Commission for the Protection against Sanitary Risk (COFEPRIS) to market and sell its Reveal rapid HIV antibody test ( Reveal HIV) in Mexico. Reveal HIV is the first rapid HIV test to be approved and sold in Mexico that is available in an all-inclusive point-of-care format.

In addition to the point-of-care format, MedMira's distribution partner in Mexico, Diagno Medical, will also sell Reveal HIV in two laboratory formats to optimise user needs in all testing environments, from the laboratory to the point-of-care. Built on MedMira's patented Rapid Vertical Flow technology, Reveal HIV delivers result instantly with a three step procedure. Other rapid tests on the market are claimed to take anywhere from 15-40 minutes to deliver a result, while Reveal HIV takes less than two minutes.

The approval of Reveal HIV in Mexico is one of several that MedMira has recently achieved in Latin America. The company is also pursuing product approvals for the Reveal and Multiplo ranges in Panama, Ecuador, Brazil and Argentina as part of its ongoing expansion in the region.

This article is tagged to:
Related sectors of this article: Medical Devices, Regulatory - Medical Devices, PoC Diagnostics, Diagnostics
Geography: Mexico, Canada